Schizophrenia Research Forum - A Catalyst for Creative Thinking


Coyle JT, Tsai G. The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia. Psychopharmacology (Berl). 2004 Jun ; 174(1):32-8. Pubmed Abstract